MEDIAN TECHNOLOGIES News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

08.07.22	Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy® (Businesswire)
07.07.22	Median Technologies to host a live webcast and provide a company update on July 12, 2022 (Businesswire)
13.06.22	Bryan Garnier & Co Initiates the Coverage of Median Technologies with a "Buy” Recommendation (Businesswire)
02.06.22	Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA (Businesswire)
31.05.22	Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy® Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials (Businesswire)
23.05.22	Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022 (Businesswire)
05.05.22	Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device (Businesswire)
21.04.22	Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022 (Businesswire)
25.03.22	Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022 (Businesswire)
22.03.22	Median Technologies Announces Design Completion of its iBiopsy® Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance (Businesswire)
03.03.22	Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device (Businesswire)
01.03.22	Median Technologies to Participate in the Cowen’s 42nd Annual Health Care Conference (Businesswire)
09.07.21	Median Technologies: Financial Communication Schedule for the Second Half Of 2021 (Businesswire)
08.07.21	Median Technologies' Business Continues to Grow at a Steady Pace in the First Half of 2021 (Unaudited Figures) (Businesswire)
08.04.21	Median Technologies Is Releasing Full Year 2020 Financial Results (audited) as Well as Q1 2021 Business Activity Indicators, Showing a Very Strong Growth (Businesswire)
16.02.21	iBiopsy®: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS) (Businesswire)
09.02.21	iBiopsy®: Median Technologies Inks a Major Research Collaboration Agreement With the University of California San Diego (UC San Diego) (Businesswire)
14.01.21	Median Technologies Records a 51 % Increase of Its 2020 Annual Revenue (Unaudited Figures) (Businesswire)
05.01.21	Median Technologies: Financial Communications Schedule for the First Half of 2021 (Businesswire)
20.10.20	Median Technologies Records Its Eighth Consecutive Quarter of Revenue Growth (Businesswire)
14.10.20	Median Technologies Announces its H1 2020 Results (Businesswire)
08.09.20	Median Technologies: Promising Results on the Use of the IBiopsy® Platform in the Context of Measuring the Anti-tumor Immune Response (Businesswire)
27.08.20	Median Technologies: Financial Communications Schedule for the Second Half Of 2020 (Businesswire)
10.07.20	Half Year Median Technologies Liquidity Contract Statement Contracted with Louis Capital Markets UK LLP (Businesswire)
08.07.20	Median Technologies: Strong Business Activity for the First Half of 2020 (Unaudited Figures) (Businesswire)
06.07.20	Median Technologies Is Awarded the Euronext European Rising Tech Label (Businesswire)
01.07.20	Median Technologies to Host a Live Webcast and Provide a Company Update on July 9th, 2020 (Businesswire)
25.06.20	Median Technologies Appoints Oern Stuge MD, MBA, to Its Board of Directors (Businesswire)
17.06.20	Median Technologies: iBiopsy®: Promising Results on a Preliminary Study to Evaluate the Risk of Tumor Recurrence in Patients With Primary Liver Cancer (Businesswire)
04.05.20	Median Technologies: Liquidity Contract Transfer to Louis Capital Markets (Businesswire)
20.04.20	Median Technologies Receives a Disbursement of €15 Million, Corresponding to the First Tranche of the Loan Granted by the European Investment Bank (Businesswire)
14.04.20	Median Technologies Reports Full Year 2019 Financial Results (Businesswire)
02.03.20	Assistance Publique – Hôpitaux de Paris (AP-HP) And Median Technologies Reach a Research Collaboration Agreement Involving The iBiopsy® Platform (Businesswire)
20.01.20	Median Technologies: Financial Communications Schedule for the First Half of 2020 (Businesswire)
13.01.20	Median Technologies Announces Preliminary 2019 Unaudited Financial Results (Businesswire)
18.12.19	Median Technologies Announces the Signing of a € 35 Million Finance Contract with the European Investment Bank (EIB) (Businesswire)
08.10.19	Median Technologies’ Q3 Performance Shows Steady Growth, Validates the Strategy Adopted in 2018 (unaudited Figures) (Businesswire)
03.10.19	Median Technologies Reports Its Financial Results for H1 2019 (Businesswire)
11.07.19	Median Technologies Announces Preliminary H1 2019 Unaudited Financial Results (Businesswire)
08.07.19	AG Mednet and Median Technologies Partnership Supports Global Clinical Trials Portfolio, Including Extensive Programs in China (Businesswire)
28.06.19	Median Technologies: Financial Communications Schedule for the Second Half of 2019 (Businesswire)
21.05.19	Median Technologies to Attend the 2019 ASCO Annual Meeting, May 31 - June 4, 2019, McCormick Place, Chicago, IL, USA (Businesswire)
11.04.19	Median Technologies Reports Full Year 2018 Financial Results (Businesswire)
26.02.19	Median Technologies to Participate in the Cowen and Company 39th Annual Health Care Conference in Boston (Businesswire)
20.02.19	Median Technologies to Attend the 2019 European Congress of Radiology (ECR) from February 27 to March 3, 2019 in Vienna, Austria (Businesswire)
07.02.19	Median Technologies Provides a Company Update and Announces Preliminary Full Year 2018 Unaudited Financial Results (Businesswire)
01.02.19	Median Technologies: Financial Communications Schedule for the First Half of 2019 (Businesswire)
13.12.18	Median Technologies Appoints Dr. Nozha Boujemaa as Chief Science and Innovation Officer (Businesswire)
11.10.18	Median Technologies Reports Its Financial Results for H1 2018 and Announces Its Strategic Shift in Focus to Its Imaging Phenomics Platform iBiopsy® (Businesswire)
12.07.18	Median Technologies Receives the Forbes 2018 Futur40 Award and Special Recognition Prize for the "Health-Life Sciences” Company Category (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	510.00	3.09 %	K V
UBS Group	29.96	1.97 %	K V
Zurich Insur Gr	537.60	1.55 %	K V
Logitech Intl	80.34	1.47 %	K V
Swiss Life Hldg	717.00	1.36 %	K V
Kuehne+Nagel Int	200.90	0.45 %	K V
Swisscom	509.00	0.30 %	K V
Alcon	75.84	0.18 %	K V
Nestle	73.66	-0.67 %	K V
CieFinRichemont	139.05	-0.82 %	K V